{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:20:12Z","timestamp":1783707612315,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein J"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10930-020-09886-0","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T20:14:20Z","timestamp":1610741660000},"page":"133-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Structure-Based Immunogenicity Prediction of Uricase from Fungal (Aspergillus flavus), Bacterial (Bacillus subtillis) and Mammalian Sources Using Immunoinformatic Approach"],"prefix":"10.1007","volume":"39","author":[{"given":"Shikha","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8735-479X","authenticated-orcid":false,"given":"Awanish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,27]]},"reference":[{"key":"9886_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20061269","volume":"20","author":"S Yainoy","year":"2019","unstructured":"Yainoy S, Phuadraksa T, Wichit S et al (2019) Production and characterization of recombinant wild type uricase from indonesian coelacanth (L. menadoensis) and improvement of its thermostability by in silico rational design and disulphide bridges engineering. Int J Mol Sci 20:1\u201320. https:\/\/doi.org\/10.3390\/ijms20061269","journal-title":"Int J Mol Sci"},{"key":"9886_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-403-2_10","author":"N Schlesinger","year":"2008","unstructured":"Schlesinger N (2008) Hyperuricemia, gout, and diet. Nutr Rheum Dis. https:\/\/doi.org\/10.1007\/978-1-59745-403-2_10","journal-title":"Nutr Rheum Dis"},{"key":"9886_CR3","unstructured":"S Ebrahimi, M Shafiei, A Ghasemian, SKS Mostafavi, RJ Nojoomi Cloning expression assessment of uricase gene from. 10:672\u2013677"},{"key":"9886_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03007995.2017.1378502","volume":"33","author":"C Borghi","year":"2017","unstructured":"Borghi C (2017) The management of hyperuricemia: back to the pathophysiology of uric acid. Curr Med Res Opin 33:1\u20134. https:\/\/doi.org\/10.1080\/03007995.2017.1378502","journal-title":"Curr Med Res Opin"},{"key":"9886_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-5996-4-12","volume":"4","author":"EP De Oliveira","year":"2012","unstructured":"De Oliveira EP, Burini RC (2012) High plasma uric acid concentration: Causes and consequences. Diabetol Metab Syndr 4:1\u20137. https:\/\/doi.org\/10.1186\/1758-5996-4-12","journal-title":"Diabetol Metab Syndr"},{"key":"9886_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-017-0841-3","volume":"7","author":"M Imani","year":"2017","unstructured":"Imani M, Shahmohamadnejad S (2017) Recombinant production of Aspergillus flavus uricase and investigation of its thermal stability in the presence of raffinose and lactose. 3 Biotech 7:1\u20139. https:\/\/doi.org\/10.1007\/s13205-017-0841-3","journal-title":"3 Biotech"},{"key":"9886_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.biortech.2007.01.048","volume":"99","author":"WA Lotfy","year":"2008","unstructured":"Lotfy WA (2008) Production of a thermostable uricase by a novel Bacillus thermocatenulatus strain. Bioresour Technol 99:699\u2013702. https:\/\/doi.org\/10.1016\/j.biortech.2007.01.048","journal-title":"Bioresour Technol"},{"key":"9886_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/10826068.2017.1381623","volume":"48","author":"SV Pawar","year":"2018","unstructured":"Pawar SV, Rathod VK (2018) Optimization of novel and greener approach for the coproduction of uricase and alkaline protease in Bacillus licheniformis by Box-Behnken model. Prep Biochem Biotechnol 48:24\u201333. https:\/\/doi.org\/10.1080\/10826068.2017.1381623","journal-title":"Prep Biochem Biotechnol"},{"key":"9886_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/08998280.2005.11928082","volume":"18","author":"S Ueng","year":"2005","unstructured":"Ueng S (2005) Rasburicase (Elitek): a novel agent for tumor lysis Syndrome. Baylor Univ Med Cent Proc 18:275\u2013279. https:\/\/doi.org\/10.1080\/08998280.2005.11928082","journal-title":"Baylor Univ Med Cent Proc"},{"key":"9886_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/https","volume":"23","author":"V Parente","year":"2017","unstructured":"Parente V, Corti S (2017) When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies. Ther Adv Neurol Disord 23:153\u2013156. https:\/\/doi.org\/10.1177\/https","journal-title":"Ther Adv Neurol Disord"},{"key":"9886_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1515\/biolog-2016-0040","volume":"71","author":"E Kotb","year":"2016","unstructured":"Kotb E (2016) Improvement of uricase production from Bacillus subtilis RNZ-79 by solid state fermentation of shrimp shell wastes. Biol 71:229\u2013238. https:\/\/doi.org\/10.1515\/biolog-2016-0040","journal-title":"Biol"},{"key":"9886_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/674908","author":"P Pfrimer","year":"2010","unstructured":"Pfrimer P, De Moraes LMP, Galdino AS et al (2010) Cloning, purification, and partial characterization of bacillus subtilis urate oxidase expressed in escherichia coli. J Biomed Biotechnol. https:\/\/doi.org\/10.1155\/2010\/674908","journal-title":"J Biomed Biotechnol"},{"key":"9886_CR13","first-page":"658","volume":"27","author":"E Wipfler-Frei\u00dfmuth","year":"2009","unstructured":"Wipfler-Frei\u00dfmuth E, Dejaco C, Duftner C et al (2009) Urate oxidase (rasburicase) for treatment of severe acute gout: a case report. Clin Exp Rheumatol 27:658\u2013660","journal-title":"Clin Exp Rheumatol"},{"key":"9886_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1345\/aph.1Q593","volume":"46","author":"JA Shannon","year":"2012","unstructured":"Shannon JA, Cole SW (2012) Pegloticasa: un agente novel para el tratamiento de gota refractaria. Ann Pharmacother 46:368\u2013376. https:\/\/doi.org\/10.1345\/aph.1Q593","journal-title":"Ann Pharmacother"},{"key":"9886_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jbspin.2012.01.004","volume":"79","author":"RP Garay","year":"2012","unstructured":"Garay RP, El-Gewely MR, Labaune JP, Richette P (2012) Therapeutic perspectives on uricases for gout. Jt Bone Spine 79:237\u2013242. https:\/\/doi.org\/10.1016\/j.jbspin.2012.01.004","journal-title":"Jt Bone Spine"},{"key":"9886_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0167935","volume":"11","author":"AC Nyborg","year":"2016","unstructured":"Nyborg AC, Ward C, Zacco A et al (2016) A therapeutic uricase with reduced immunogenicity risk and improved development properties. PLoS ONE 11:1\u201323. https:\/\/doi.org\/10.1371\/journal.pone.0167935","journal-title":"PLoS ONE"},{"key":"9886_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-1-4939-7841-0_18","volume":"1785","author":"M Andreatta","year":"2018","unstructured":"Andreatta M, Nielsen M (2018) Bioinformatics tools for the prediction of T-cell epitopes. Methods Mol Biol 1785:269\u2013281. https:\/\/doi.org\/10.1007\/978-1-4939-7841-0_18","journal-title":"Methods Mol Biol"},{"key":"9886_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00436-017-5408-z","volume":"116","author":"SK Panda","year":"2017","unstructured":"Panda SK, Mahapatra RK (2017) In-silico screening, identification and validation of a novel vaccine candidate in the fight against Plasmodium falciparum. Parasitol Res 116:1293\u20131305. https:\/\/doi.org\/10.1007\/s00436-017-5408-z","journal-title":"Parasitol Res"},{"key":"9886_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.01369","volume":"9","author":"SK Dhanda","year":"2018","unstructured":"Dhanda SK, Karosiene E, Edwards L et al (2018) Predicting HLA CD4 immunogenicity in human populations. Front Immunol 9:1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2018.01369","journal-title":"Front Immunol"},{"key":"9886_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1107\/S0907444903029718","volume":"60","author":"P Retailleau","year":"2004","unstructured":"Retailleau P, Colloc\u2019h N, Vivar\u00e8s D et al (2004) Complexed and ligand-free high-resolution structures of urate oxidase (Uox) from Aspergillus flavus: a reassignment of the active-site binding mode. Acta Crystallogr Sect D 60:453\u2013462. https:\/\/doi.org\/10.1107\/S0907444903029718","journal-title":"Acta Crystallogr Sect D"},{"key":"9886_CR21","unstructured":"Jiang YY Structure of urate oxidase from Bacillus subtilis 168."},{"key":"9886_CR22","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1073\/pnas.1320393111","volume":"111","author":"JT Kratzer","year":"2014","unstructured":"Kratzer JT, Lanaspa MA, Murphy MN et al (2014) Evolutionary history and metabolic insights of ancient mammalian uricases. Proc Natl Acad Sci USA 111:3763\u20133768. https:\/\/doi.org\/10.1073\/pnas.1320393111","journal-title":"Proc Natl Acad Sci USA"},{"key":"9886_CR23","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen MC, Peters B, Nielsen M, Marcatili P (2017) BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res 45:W24\u2013W29. https:\/\/doi.org\/10.1093\/nar\/gkx346","journal-title":"Nucleic Acids Res"},{"key":"9886_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko J, Bui HH, Li W et al (2008) ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform 9:1\u20138. https:\/\/doi.org\/10.1186\/1471-2105-9-514","journal-title":"BMC Bioinform"},{"key":"9886_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000048","author":"P Wang","year":"2008","unstructured":"Wang P, Sidney J, Dow C et al (2008) A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol. https:\/\/doi.org\/10.1371\/journal.pcbi.1000048","journal-title":"PLoS Comput Biol"},{"key":"9886_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/1471-2105-11-568","volume":"11","author":"P Wang","year":"2010","unstructured":"Wang P, Sidney J, Kim Y et al (2010) Peptide binding predictions for HLA, DR, DP and DQ molecules. BMC Bioinform 11:568. https:\/\/doi.org\/10.1186\/1471-2105-11-568","journal-title":"BMC Bioinform"},{"key":"9886_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00251-015-0873-y","volume":"67","author":"M Andreatta","year":"2015","unstructured":"Andreatta M, Karosiene E, Rasmussen M et al (2015) Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Immunogenetics 67:641\u2013650. https:\/\/doi.org\/10.1007\/s00251-015-0873-y","journal-title":"Immunogenetics"},{"key":"9886_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-238","volume":"8","author":"M Nielsen","year":"2007","unstructured":"Nielsen M, Lundegaard C, Lund O (2007) Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinform 8:1\u201312. https:\/\/doi.org\/10.1186\/1471-2105-8-238","journal-title":"BMC Bioinform"},{"key":"9886_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1471-2105-10-296","volume":"10","author":"M Nielsen","year":"2009","unstructured":"Nielsen M, Lund O (2009) NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinform 10:296. https:\/\/doi.org\/10.1186\/1471-2105-10-296","journal-title":"BMC Bioinform"},{"key":"9886_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-7580-4-2","volume":"4","author":"J Sidney","year":"2008","unstructured":"Sidney J, Assarsson E, Moore C et al (2008) Quantitative peptide binding motifs for 19 human and mouse MHC class i molecules derived using positional scanning combinatorial peptide libraries. Immunome Res 4:1\u201314. https:\/\/doi.org\/10.1186\/1745-7580-4-2","journal-title":"Immunome Res"},{"key":"9886_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/9858","volume":"17","author":"T Sturniolo","year":"1999","unstructured":"Sturniolo T, Bono E, Ding J et al (1999) Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 17:555\u2013561. https:\/\/doi.org\/10.1038\/9858","journal-title":"Nat Biotechnol"},{"key":"9886_CR32","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/nar\/gkq1128","volume":"39","author":"FF Gonzalez-Galarza","year":"2011","unstructured":"Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 39:913\u2013919. https:\/\/doi.org\/10.1093\/nar\/gkq1128","journal-title":"Nucleic Acids Res"},{"key":"9886_CR33","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.4049\/jimmunol.175.6.3603","volume":"175","author":"J Schulze zur Wiesch","year":"2005","unstructured":"Schulze zur Wiesch J, Lauer GM, Day CL et al (2005) Broad repertoire of the CD4 + Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 175:3603\u20133613. https:\/\/doi.org\/10.4049\/jimmunol.175.6.3603","journal-title":"J Immunol"},{"key":"9886_CR34","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nbt1215","volume":"24","author":"M Moutaftsi","year":"2006","unstructured":"Moutaftsi M, Peters B, Pasquetto V et al (2006) A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus. Nat Biotechnol 24:817\u2013819. https:\/\/doi.org\/10.1038\/nbt1215","journal-title":"Nat Biotechnol"},{"key":"9886_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-014-2278-5","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov I, Bangov I, Flower DR, Doytchinova I (2014) AllerTOP vol 2\u2014a server for in silico prediction of allergens. J Mol Model. https:\/\/doi.org\/10.1007\/s00894-014-2278-5","journal-title":"J Mol Model"},{"key":"9886_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1600-065X.1975.tb00150.x","volume":"23","author":"M Feldmann","year":"1975","unstructured":"Feldmann M, Howard JG, Desaymard C (1975) Role of Antigen structure in the discrimination between tolerance and immunity by B cells. Immunol Rev 23:78\u201397. https:\/\/doi.org\/10.1111\/j.1600-065X.1975.tb00150.x","journal-title":"Immunol Rev"},{"key":"9886_CR37","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1126\/science.8248784","volume":"262","author":"MF Bachmann","year":"1993","unstructured":"Bachmann MF, Rohrer UH, K\u00fcndig TM et al (1993) The influence of antigen organization on B cell responsiveness. Science 262:1448\u20131451. https:\/\/doi.org\/10.1126\/science.8248784","journal-title":"Science"},{"key":"9886_CR38","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.4049\/jimmunol.171.3.1148","volume":"171","author":"P Aichele","year":"2003","unstructured":"Aichele P, Zinke J, Grode L et al (2003) Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T Cell responses. J Immunol 171:1148\u20131155. https:\/\/doi.org\/10.4049\/jimmunol.171.3.1148","journal-title":"J Immunol"},{"key":"9886_CR39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.vaccine.2004.05.028","volume":"23","author":"W Liu","year":"2004","unstructured":"Liu W, Peng Z, Liu Z et al (2004) High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity. Vaccine 23:366\u2013371. https:\/\/doi.org\/10.1016\/j.vaccine.2004.05.028","journal-title":"Vaccine"},{"key":"9886_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4314\/aipm.v6i1.64038","volume":"6","author":"T Dahiru","year":"2011","unstructured":"Dahiru T (2011) P-Value, a true test of statistical significance a cautionary note. Ann Ibadan Postgrad Med 6:21\u201326. https:\/\/doi.org\/10.4314\/aipm.v6i1.64038","journal-title":"Ann Ibadan Postgrad Med"},{"key":"9886_CR41","unstructured":"Of H, Information P, Changes RM et al (2012) Full prescribing information: contents * 1 indications and usage 2 dosage and administration 7. 2 potential for altered drug absorption 8 use in specific populations 3 dosage forms and strengths 4 contraindications 5 warnings and precautions 5. 1 Serio. 1\u201322"},{"key":"9886_CR42","unstructured":"Rasburicase (Elitek). Rasburicase (Elitek) 1\u201312."},{"key":"9886_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/138945009787354511","volume":"10","author":"M Onda","year":"2009","unstructured":"Onda M (2009) Reducing the immunogenicity of protein therapeutics. Curr Drug Targets 10:131\u2013139. https:\/\/doi.org\/10.2174\/138945009787354511","journal-title":"Curr Drug Targets"},{"key":"9886_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008335.pub2","author":"A Anderson","year":"2010","unstructured":"Anderson A, Singh JA (2010) Pegloticase for chronic gout (review) summary of findings for the main comparison. Cochrane DB Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008335.pub2","journal-title":"Cochrane DB Syst Rev"},{"key":"9886_CR45","volume-title":"Anti-inflammatory and antipyretic analgesics and drugs used in gout","author":"G Masclee","year":"2014","unstructured":"Masclee G (2014) Anti-inflammatory and antipyretic analgesics and drugs used in gout. Elsevier, Amsterdam"},{"key":"9886_CR46","doi-asserted-by":"publisher","DOI":"10.1177\/2042098617727714","author":"A Guttmann","year":"2017","unstructured":"Guttmann A, Krasnokutsky S, Pillinger MH, Berhanu A (2017) Pegloticase in gout treatment-safety issues, latest evidence and clinical considerations. Ther Adv Drug Saf. https:\/\/doi.org\/10.1177\/2042098617727714","journal-title":"Ther Adv Drug Saf"}],"container-title":["The Protein Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-020-09886-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10930-020-09886-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-020-09886-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:25:55Z","timestamp":1667521555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10930-020-09886-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["9886"],"URL":"https:\/\/doi.org\/10.1007\/s10930-020-09886-0","relation":{},"ISSN":["1572-3887","1875-8355"],"issn-type":[{"value":"1572-3887","type":"print"},{"value":"1875-8355","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,27]]},"assertion":[{"value":"27 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors have declared that they don\u2019t have a conflict of interest in publishing the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}}]}}